Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-28

Clinical Trial Update: Doxecitin and Doxribthymine in Adult Subjects With Thymidine Kinase 2 (TK2) Deficiency [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on Doxecitin and Doxribthymine for adults with thymidine kinase 2 deficiency–related mitochondrial myopathies, currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Doxecitin
  • Doxribthymine

Snippet

Sponsor: Cristina Domínguez González | Conditions: Thymidine Kinase 2 (TK2 ) Deficiency, Mitochondrial Myopathies | Phase 2 | Status: RECRUITING